BillionaireNet
Kharitonin
Viktor Kharitonin
Rank #486
RUSSIAHealthcarePharmaceuticals

Viktor Kharitonin

Net Worth
$7.526B
0% (24h)
Viktor Kharitonin is a prominent Russian billionaire with a net worth estimated at $7.5 billion as of December 2025. His wealth stems primarily from his co-founding of Pharmstandard in 2003 with Roman Abramovich, a multinational pharmaceutical firm, where he serves as chairman. His career has been centered in the pharmaceutical industry, and his achievements include building Pharmstandard into a leading pharmaceutical company, listing it on the London Stock Exchange, and later taking it private. He is also known for owning the Nürburgring race track in Germany.

The Full Dossier

Early Life and Education

Viktor Vladimirovich Kharitonin was born on November 20, 1972, in Novosibirsk, Russia. Little information is available about his early life. He graduated from Novosibirsk State University with a degree in economics.

Rise to Success

Kharitonin's career began in the early 1990s, a time of significant economic and political change in Russia. He saw an opportunity in the pharmaceutical industry, founding Pharmstandard in 2003 with Roman Abramovich. Pharmstandard was created by combining five factories. In 2008, Pharmstandard was listed on the London Stock Exchange. Kharitonin and his partner, Egor Kulkov, took Pharmstandard private again in 2016. In November 2021, Kharitonin acquired the TSS group through Augment Investments.

Key Business Strategies

Kharitonin's key strategy has been to focus on the pharmaceutical industry, building Pharmstandard into a major player in Russia. He expanded his business portfolio by acquiring the TSS group in 2021. In October 2014 Kharitonin became co-owner of Nurbugring in Germany.

Philanthropy

Viktor Kharitonin is known for his philanthropic efforts, particularly in healthcare and education. He has funded programs addressing health issues and supported infrastructure development.

Career Timeline

2014

Co-owner of Nurburgring

Kharitonin became a co-owner of the Nürburgring race track in Germany.

2021

Acquired TSS group

Kharitonin acquired the TSS group through Augment Investments.

2016

Privatized Pharmstandard

Kharitonin and Egor Kulkov took Pharmstandard private, buying out the shares and delisting from the London Stock Exchange.

2008

Pharmstandard Listed on London Stock Exchange

Pharmstandard was listed on the London Stock Exchange.

2003

Co-founded Pharmstandard

Co-founded Pharmstandard with Roman Abramovich, a multinational pharmaceutical firm.

Philanthropic Impact

Healthcare$XB

Healthcare Initiatives

Supports healthcare infrastructure development, including construction and modernization of hospitals.

Education$XB

Education Support

Funds programs to support educational institutions and scientific research.

Wealth Trajectory